The Role of Theophylline Plus Low-dose Formoterol-budesonide in Treatment of Bronchiectasis

NCT01769898 Phase 4 COMPLETED

The purpose of this study is to examine the efficacy and safety of 24 weeks treatment with theophylline plus low-dose formoterol-budesonide in subjects with bronchiectasis.

Details

Lead sponsor	The First Affiliated Hospital of Guangzhou Medical University
Phase	Phase 4
Status	COMPLETED
Enrolment	50
Start date	2013-07
Completion	2014-11

Conditions

• Bronchiectasis

Interventions

• Formoterol-budesonide
• Theophylline
• Placebo

Primary outcomes

• Quality of Life Assessment with St George's Respiratory Questionnaire(SGRQ) and Leicester Cough Questionnaire(LCQ) — Baseline and 24 weeks

Countries

China